Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 1.000 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.522 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.522 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.507 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.504 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.503 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.502 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.489 | |
| 4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.485 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.481 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.481 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.480 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.476 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.472 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.469 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.469 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.469 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.467 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.464 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.464 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.463 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.462 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.460 | |
| 3cok | ANP | Serine/threonine-protein kinase PLK4 | 2.7.11.21 | 0.458 | |
| 5ap5 | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.458 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.457 | |
| 2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.456 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.455 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.455 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.455 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
| 3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.449 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.448 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.447 | |
| 5eg3 | ACP | Fibroblast growth factor receptor 2 | / | 0.447 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.446 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.445 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.442 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.441 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.440 | |
| 5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.440 |